ArticleJournal of molecular biology2025
Saccharomyces cerevisiae Xrs2 Binds DNA Through Its FHA Domain.
Article in Journal of molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The MRE11-RAD50-NBS1/Xrs2 (MRN/X) complex is a conserved first responder to DNA double-strand breaks (DSBs). All three members of the complex have DNA binding properties that support the range of functions MRN/X performs in its role in DNA DSB repair. Previous structural and functional studies have localized DNA binding sites within MRE11 and RAD50, but no structural model exists for DNA association with NBS1/Xrs2. Here, we identify a DNA binding site within the N-terminal folded FHA-BRCT-BRCT domain of Saccharomyces cerevisiae Xrs2. Using NMR chemical shift perturbations and paramagnetic relaxation enhancements, we define a DNA binding interface on the FHA domain and generate integrative models of the DNA-bound complex via the program HADDOCK. DNA binding overlaps with the site involved in phosphorylated Sae2 peptide binding - an interaction analogous to that between Schizosaccharomyces pombe Nbs1 and phosphorylated Ctp1. Comparative binding assays and site-directed mutagenesis confirm a shared binding surface for DNA and pSae2 on the FHA domain of Xrs2 and highlight the need for functional assays and mutagenesis for validating HADDOCK models. Finally, NMR relaxation experiments reveal altered ps-ns timescale dynamics but unaltered µs-ms conformational exchange upon ligand binding. These findings define a direct DNA binding role for Xrs2 and provide a structural framework for understanding its dual recognition of DNA and phosphoprotein partners during DSB repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.